These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 5016002)

  • 1. Chemically induced degeneration of indoleamine-containing nerve terminals in rat brain.
    Baumgarten HG; Lachenmayer L
    Brain Res; 1972 Mar; 38(1):228-32. PubMed ID: 5016002
    [No Abstract]   [Full Text] [Related]  

  • 2. Effects of 5-methoxy-N,N-dimethyltryptamine on central monoamine neurons.
    Fuxe K; Holmstedt B; Jonsson G
    Eur J Pharmacol; 1972 Jul; 19(1):25-34. PubMed ID: 4403108
    [No Abstract]   [Full Text] [Related]  

  • 3. Evidence for a degeneration of indoleamine containing nerve terminals in rat brain, induced by 5,6-dihydroxytryptamine.
    Baumgarten HG; Lachenmayer L; Schlossberger HG
    Z Zellforsch Mikrosk Anat; 1972; 125(4):553-69. PubMed ID: 5011361
    [No Abstract]   [Full Text] [Related]  

  • 4. Neurotoxicity of hydroxylated tryptamines: structure-activity relationships. 1. Long-term effects on monoamine content and fluorescence morphology of central monoamine neurons.
    Baumgarten HG; Björklund A; Nobin A; Rosengren E; Schlossberger HG
    Acta Physiol Scand Suppl; 1975; 429():5-27. PubMed ID: 1064287
    [No Abstract]   [Full Text] [Related]  

  • 5. Neuronal degeneration in rat brain induced by 6-hydroxydopamine; a histological and biochemical study.
    Hedreen JC; Chalmers JP
    Brain Res; 1972 Nov; 47(1):1-36. PubMed ID: 4345031
    [No Abstract]   [Full Text] [Related]  

  • 6. Effects of 5,6-dihydroxytryptamine on monoaminergic neurones in the central nervous system of the rat.
    Baumgarten HG; Evetts KD; Holman RB; Iversen LL; Vogt M; Wilson G
    J Neurochem; 1972 Jun; 19(6):1587-97. PubMed ID: 4402486
    [No Abstract]   [Full Text] [Related]  

  • 7. Ultrastructural changes in the nerve endings of the median eminence after nialamide-DOPA administration.
    De Iraldi AP; Etcheverry GJ
    Brain Res; 1967 Nov; 6(3):614-8. PubMed ID: 6079719
    [No Abstract]   [Full Text] [Related]  

  • 8. Calcium-dependent release of endogenous serotonin, dopamine and norepinephrine from nerve endings.
    Lane JD; Aprison MH
    Life Sci; 1977 Feb; 20(4):665-71. PubMed ID: 839983
    [No Abstract]   [Full Text] [Related]  

  • 9. Kinetic studies on rat brain monoamine oxidase.
    Huszti Z
    Mol Pharmacol; 1972 Jul; 8(4):385-97. PubMed ID: 5053580
    [No Abstract]   [Full Text] [Related]  

  • 10. Uptake of exogenous catecholamines by monoamine-containing neurons of the central nervous system: uptake of catecholamines by arcuato-infundibular neurons.
    Lichtensteiger W; Langemann H
    J Pharmacol Exp Ther; 1966 Mar; 151(3):400-8. PubMed ID: 5938477
    [No Abstract]   [Full Text] [Related]  

  • 11. Serotonin and catecholamine concentrations in brain of rats injected intracerebrally with 5,6-dihydroxytryptamine.
    Costa E; LeFevre H; Meek J; Revuelta A; Spano F; Strada S; Daly J
    Brain Res; 1972 Sep; 44(1):304-8. PubMed ID: 5056985
    [No Abstract]   [Full Text] [Related]  

  • 12. Microspectrofluorimetric studies on central 5-hydroxytryptamine neurons.
    Jonsson G; Einarsson P; Fuxe K; Hallman H
    Adv Biochem Psychopharmacol; 1974; 10():55-65. PubMed ID: 4276959
    [No Abstract]   [Full Text] [Related]  

  • 13. Differential monoamine depletion by oxypertine in nerve terminals. Granulated synaptic vesicles in relation to depletion of norepinephrine, dopamine and serotonin.
    Bak IJ; Hassler R; Kim JS
    Z Zellforsch Mikrosk Anat; 1969; 101(3):448-62. PubMed ID: 5362847
    [No Abstract]   [Full Text] [Related]  

  • 14. Delay in nerve degeneration after sympathectomy of the submaxillary gland of the rat by treatment with pargyline, nialamide or beta-TM-10.
    Arbilla S; Perec CJ; Stefano FJ
    J Pharmacol Exp Ther; 1977 Sep; 202(3):622-34. PubMed ID: 894525
    [No Abstract]   [Full Text] [Related]  

  • 15. Localization of 5-hydroxytryptamine uptake in rat brain after intraventricular injection.
    Fuxe K; Ungerstedt U
    J Pharm Pharmacol; 1967 May; 19(5):335-7. PubMed ID: 4382408
    [No Abstract]   [Full Text] [Related]  

  • 16. Effects of 5-hydroxytryptophan on serotonin in nerve endings.
    McBride WJ; Aprison MH; Hingtgen JN
    J Neurochem; 1974 Aug; 23(2):385-91. PubMed ID: 4547408
    [No Abstract]   [Full Text] [Related]  

  • 17. The effect of nerve stimulation on the uptake of noradrenaline into the adrenergic nerve terminals.
    Häggendal J; Malmfors T
    Acta Physiol Scand; 1969; 75(1):28-32. PubMed ID: 4306629
    [No Abstract]   [Full Text] [Related]  

  • 18. Effects of amantadine hydrochloride on catecholamine metabolism in the brain of the rat.
    Baldessarini RJ; Lipinski JF; Chace KV
    Biochem Pharmacol; 1972 Jan; 21(1):77-87. PubMed ID: 5058704
    [No Abstract]   [Full Text] [Related]  

  • 19. Toxicity and the action of reserpine on brain monoamines after pretreatment with monoamine oxidase inhibitors in isolated and aggregated mice.
    Pfeifer AK; Galambos E
    Psychopharmacologia; 1967; 11(2):130-5. PubMed ID: 5588185
    [No Abstract]   [Full Text] [Related]  

  • 20. Effects of 5,6-dihydroxytryptamine on nerve terminal serotonin and serotonin uptake in the rat brain.
    Björklund A; Nobin A; Stenevi U
    Brain Res; 1973 Apr; 53(1):117-27. PubMed ID: 4697240
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.